These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 24177413)

  • 1. Rationale, design, and baseline characteristics of a community-based comparative effectiveness trial to prevent type 2 diabetes in economically disadvantaged adults: the RAPID Study.
    Ackermann RT; Finch EA; Schmidt KK; Hoen HM; Hays LM; Marrero DG; Saha C
    Contemp Clin Trials; 2014 Jan; 37(1):1-9. PubMed ID: 24177413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The rationale, design, and baseline characteristics of PREVENT-DM: A community-based comparative effectiveness trial of lifestyle intervention and metformin among Latinas with prediabetes.
    Perez A; Alos VA; Scanlan A; Maia CM; Davey A; Whitaker RC; Foster GD; Ackermann RT; O'Brien MJ
    Contemp Clin Trials; 2015 Nov; 45(Pt B):320-327. PubMed ID: 26597415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and participant characteristics for a randomized effectiveness trial of an intensive lifestyle intervention to reduce cardiovascular risk in adults with type 2 diabetes: The I-D-HEALTH study.
    Liss DT; Finch EA; Gregory DL; Cooper A; Ackermann RT
    Contemp Clin Trials; 2016 Jan; 46():114-121. PubMed ID: 26611433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Randomized Comparative Effectiveness Trial for Preventing Type 2 Diabetes.
    Ackermann RT; Liss DT; Finch EA; Schmidt KK; Hays LM; Marrero DG; Saha C
    Am J Public Health; 2015 Nov; 105(11):2328-34. PubMed ID: 26378828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Financial incentives for diabetes prevention in a Medicaid population: Study design and baseline characteristics.
    Desai J; Taylor G; Vazquez-Benitez G; Vine S; Anderson J; Garrett JE; Gilmer T; Vue-Her H; Schiff J; Rinn S; Engel K; Michael A; O'Connor PJ
    Contemp Clin Trials; 2017 Feb; 53():1-10. PubMed ID: 27890521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Community Trial of a Faith-Based Lifestyle Intervention to Prevent Diabetes Among African-Americans.
    Sattin RW; Williams LB; Dias J; Garvin JT; Marion L; Joshua TV; Kriska A; Kramer MK; Narayan KM
    J Community Health; 2016 Feb; 41(1):87-96. PubMed ID: 26215167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Lifestyle Intervention for the Treatment of Diabetes study (LIFT Diabetes): Design and baseline characteristics for a randomized translational trial to improve control of cardiovascular disease risk factors.
    Katula JA; Kirk JK; Pedley CF; Savoca MR; Effoe VS; Bell RA; Bertoni AG;
    Contemp Clin Trials; 2017 Feb; 53():89-99. PubMed ID: 27940180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Diabetes Prevention Program: baseline characteristics of the randomized cohort. The Diabetes Prevention Program Research Group.
    The Diabetes Prevention Program Research Group
    Diabetes Care; 2000 Nov; 23(11):1619-29. PubMed ID: 11092283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term effects of a community-based lifestyle intervention to prevent type 2 diabetes: the DEPLOY extension pilot study.
    Ackermann RT; Finch EA; Caffrey HM; Lipscomb ER; Hays LM; Saha C
    Chronic Illn; 2011 Dec; 7(4):279-90. PubMed ID: 21840914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The PULSE (Prevention Using LifeStyle Education) trial protocol: a randomised controlled trial of a Type 2 Diabetes Prevention programme for men.
    Aguiar EJ; Morgan PJ; Collins CE; Plotnikoff RC; Young MD; Callister R
    Contemp Clin Trials; 2014 Sep; 39(1):132-44. PubMed ID: 25092484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of an adapted version of the Diabetes Prevention Program for low- and middle-income countries: A cluster randomized trial to evaluate "Lifestyle Africa" in South Africa.
    Catley D; Puoane T; Tsolekile L; Resnicow K; Fleming KK; Hurley EA; Smyth JM; Materia FT; Lambert EV; Vitolins MZ; Levitt NS; Goggin K
    PLoS Med; 2022 Apr; 19(4):e1003964. PubMed ID: 35427357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes Prevention Program Translation in the Veterans Health Administration.
    Moin T; Damschroder LJ; AuYoung M; Maciejewski ML; Datta SK; Weinreb JE; Steinle NI; Billington C; Hughes M; Makki F; Holleman RG; Kim HM; Jeffreys AS; Kinsinger LS; Burns JA; Richardson CR
    Am J Prev Med; 2017 Jul; 53(1):70-77. PubMed ID: 28094135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proyecto Mamá: a lifestyle intervention in overweight and obese Hispanic women: a randomised controlled trial--study protocol.
    Chasan-Taber L; Marcus BH; Rosal MC; Tucker KL; Hartman SJ; Pekow P; Stanek E; Braun B; Solomon CG; Manson JE; Goff SL; Markenson G
    BMC Pregnancy Childbirth; 2015 Jul; 15():157. PubMed ID: 26223246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reducing metabolic syndrome through a community-based lifestyle intervention in African American women.
    Mamun A; Kitzman H; Dodgen L
    Nutr Metab Cardiovasc Dis; 2020 Sep; 30(10):1785-1794. PubMed ID: 32605881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of a Female Community Health Volunteer-Delivered Intervention in Reducing Blood Glucose Among Adults With Type 2 Diabetes: An Open-Label, Cluster Randomized Clinical Trial.
    Gyawali B; Sharma R; Mishra SR; Neupane D; Vaidya A; Sandbæk A; Kallestrup P
    JAMA Netw Open; 2021 Feb; 4(2):e2035799. PubMed ID: 33523189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Track: A randomized controlled trial of a digital health obesity treatment intervention for medically vulnerable primary care patients.
    Foley P; Steinberg D; Levine E; Askew S; Batch BC; Puleo EM; Svetkey LP; Bosworth HB; DeVries A; Miranda H; Bennett GG
    Contemp Clin Trials; 2016 May; 48():12-20. PubMed ID: 26995281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design of a cluster-randomized controlled trial of a diabetes prevention program within African-American churches: The Fit Body and Soul study.
    Williams LB; Sattin RW; Dias J; Garvin JT; Marion L; Joshua T; Kriska A; Kramer MK; Echouffo-Tcheugui JB; Freeman A; Narayan KM
    Contemp Clin Trials; 2013 Mar; 34(2):336-47. PubMed ID: 23354313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Steps toward the primary prevention of type II diabetes mellitus. Various epidemiological considerations].
    Flórez H
    Invest Clin; 1997 Mar; 38(1):39-52. PubMed ID: 9235072
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.